Actionable personalized results for better patient outcomes is at the center of MPLN's oncology program. Partnering with MPLN enables clinicians to access specialty and genomic testing to profile their patients cancer and manage appropriate treatment regimens, including selection for clinical trials based on the patient's genetic makeup.
With the latest technologies in sequencing, DNA analysis, fluorescence in situ hybridization, and flow cytometry, our hematopathologists have precise information to provide diagnostic, risk stratification, treatment selection, and clinical course monitoring. MPLN practices evidence-based medicine, delivering comprehensive integrated analyses while saving time and cost.
MPLN is a leader in the implementation of patient-specific reflex testing (StrataFLEX) that strategically moves clinicians through the laboratory process, addressing each stage of patient management in a consultative, timely, and cost-effective manner. Strategic step-by-step testing addresses current, targeted therapies and maximizes information for the clinician. Through StrataFLEX, diagnosis is first achieved, while simultaneously focusing on prognostic and therapy-related information, setting the stage to monitor the patient over the course of treatment.
Pharma is embracing the co-development of companion diagnostics and targeted therapies, tailoring treatments to specific sub-populations. New technologies and tools implemented by MPLN to screen, diagnose earlier, predict, and monitor the course of a disease, ensure the most appropriate, timely, and safe use of these therapies. MPLN diligently adheres to guidelines, competence, and quality metrics for patient workup, and actively engages in discussions of clinical diagnostic utility on a patient by patient basis with physicians.
Chief Medical Officer Dr. Jonathan L. Klein leads MPLN's experienced team of Pathologists. He is board certified in hematopathology, anatomic and clinical pathology, and board-eligible in molecular genetic pathology. A well-respected industry leader, Dr. Klein's team of physicians are accessible at any given time to assist and serve you.
Oncology Testing Resources